Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus - Report - MDSpire

Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus

  • By

  • Sanjiv Kandhari

  • Jayakar Thomas

  • Niti Khunger

  • Maya Vedamurthy

  • Kiran Godse

  • Abir Saraswat

  • Nina Madnani

  • Vijay Somani

  • Sushil Tahiliani

  • Bela Shah

  • C. R. Srinivas

  • Asit Mittal

  • Mukesh Girdhar

  • Maleeka Sachdeva

  • Sachin Varma

  • Manjunath Shenoy

  • Shyamanta Barua

  • Abhishek De

  • Akshay Jain

  • Aseem Sharma

  • March 31, 2026

  • 0 min

Share

Guidelines on Strategic Use of Isotretinoin for Acne Management

Overview

The ERAISE ACNE consensus provides recommendations for isotretinoin use in severe and select moderate acne cases, emphasizing early initiation post-first-line therapy failure. It advocates for risk-based monitoring and acknowledges the psychosocial impact of acne.

Background

Acne vulgaris affects a significant portion of the population, with severe cases leading to long-term consequences such as scarring and psychological distress. Effective management is crucial, particularly in patients at risk of scarring or psychological morbidity. Isotretinoin remains a key therapeutic option, yet its use is often complicated by concerns regarding side effects and inconsistent prescribing practices.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Isotretinoin is recommended as first-line therapy for severe acne and select moderate cases.
  • Early initiation of isotretinoin is endorsed to prevent progression and scarring.
  • Conventional dosing of 0.5–1 mg/kg/day is preferred for severe acne, while lower doses are acceptable for moderate cases.
  • Risk-adapted laboratory monitoring is emphasized over universal protocols.
  • Procedures like comedone extraction and chemical peels can be used during isotretinoin therapy.

Clinical Implications

Clinicians should consider early isotretinoin initiation for patients with severe acne or those at high risk for scarring. A tailored approach to monitoring and managing side effects is essential to optimize treatment outcomes.

Conclusion

The ERAISE ACNE consensus provides a structured framework for the effective use of isotretinoin in acne management, highlighting the importance of early intervention and individualized care.

Related Resources & Content

  1. Whitney Hauser, OD, Optometric Management, 2020 -- CLINICAL: Dry Eye
  2. Analysis of Fetal Exposure to Acne Medications in the U.S.: A Retrospective Study from 2006 to 2015
  3. Adherence to Isotretinoin Pregnancy Prevention Guidelines After Changes to the EU Program: A Follow-Up Study in Estonia
  4. Adherence to Contraceptive Guidelines During Isotretinoin Treatment Among Reproductive-Aged Women in Estonia from 2012 to 2016
  5. Acne Management: Guidelines From the American Academy of Dermatology | AAFP
  6. Acne Relapse and Isotretinoin Retrial in Patients With Acne | Acne | JAMA Dermatology | JAMA Network
  7. Acne Management: Guidelines From the American Academy of Dermatology | AAFP
  8. Acne Relapse and Isotretinoin Retrial in Patients With Acne | Acne | JAMA Dermatology | JAMA Network
  9. Approval Letter_021951Orig1s028;211913Orig1s013ltr.pdf

Original Source(s)

Guidelines from Experts on the Strategic Use of Isotretinoin for Optimal Acne Management: Recommendations from the ERAISE ACNE Consensus

  • by Sanjiv Kandhari, Jayakar Thomas, Niti Khunger, Maya Vedamurthy, Kiran Godse, Abir Saraswat, Nina Madnani, Vijay Somani, Sushil Tahiliani, Bela Shah, C. R. Srinivas, Asit Mittal, Mukesh Girdhar, Maleeka Sachdeva, Sachin Varma, Manjunath Shenoy, Shyamanta Barua, Abhishek De, Akshay Jain, Aseem Sharma

  • March 31, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Efficacy Assessment of Intradermal Stromal Vascular Fraction Injection Compared to Saline Injection for Treating Atrophic Acne Scars: A 10-Week, Prospective, Randomized, Split-Face, Single-Blind Study

The Bacterial Landscape of Facial Skin: From Homeostasis to Skin Conditions